v3.25.4
Segment Reporting
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Reporting

14. Segment Reporting

 

The Company's interim Chief Executive Officer, who is the Chief Operating Decision Maker ("CODM"), manages and allocates resources to the operations of the Company on a total company basis by assessing the overall level of resources available and how to best deploy these resources across functions and research and development projects that are in line with the Company's long-term company-wide strategic goals. The CODM uses the Company’s consolidated net income (loss) to monitor actual results versus the budget in assessing segment performance and the allocation of resources. The measure of segment assets is reported on the consolidated balance sheets as total assets.

 

The Company's reportable segment net income (loss) for the years ended December 31, 2025, 2024 and 2023, consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

Grant revenue

 

$

789

 

 

$

—

 

 

$

—

 

Significant segment expenses:

 

 

 

 

 

 

 

 

 

Live biotherapeutics platform

 

$

23,573

 

 

$

29,006

 

 

$

43,342

 

SER-155

 

 

3,687

 

 

 

6,804

 

 

 

7,759

 

R&D personnel-related (including stock-based compensation)

 

 

21,553

 

 

 

28,689

 

 

 

65,251

 

G&A personnel-related (including stock-based compensation)

 

 

14,413

 

 

 

22,679

 

 

 

36,069

 

Professional fees

 

 

8,991

 

 

 

9,805

 

 

 

18,784

 

Facility-related and other

 

 

15,752

 

 

 

20,699

 

 

 

22,647

 

Gain on sale of VOWST Business

 

 

(80,685

)

 

 

(5,684

)

 

 

-

 

Other segment (income) expense (1)

 

 

(12,191

)

 

 

13,773

 

 

 

(3,722

)

Net income (loss) from continuing operations

 

 

5,696

 

 

 

(125,771

)

 

 

(190,130

)

Net income from discontinued operations, net of tax (2)

 

 

—

 

 

 

125,907

 

 

 

76,406

 

Net income (loss)

 

$

5,696

 

 

$

136

 

 

$

(113,724

)

[1] Other segment (income) expense includes manufacturing services expenses, research and development expenses on early stage programs, interest income and other (income) expense, net.

[2] See Note 3, Discontinued Operations and TSA, for further details.